Analysts’ estimates

In the first quarter, Ionis Pharmaceuticals’ (IONS) revenue grew 24.7% year-over-year to $144.4 million from $115.8 million. Analysts expect Ionis’s top line to rise ~30.2% to ~$135.7 million in the second quarter. The chart below shows analysts’ recommendations for Ionis stock over the last year.

What Analysts Think about Ionis

Ionis’s stock price has fallen ~2.1% over the last 12 months and ~12.9% year-to-date. Analysts’ 12-month target price of $59.91 implies a ~36.8% return based on the stock’s May 22 price of $43.80.

Analysts’ recommendations

Of the 13 analysts tracking Ionis, one recommends “strong buy,” three recommend “buy,” seven recommend “hold,” one recommends “sell,” and one recommends “strong sell.” Their consensus rating for Ionis is 2.9, which represents a moderate “buy” for value investors. Analysts’ estimates and recommendations change based on companies’ stock prices and performance.

The First Trust NYSE Arca Biotechnology ETF (FBT) invests 2.9% of its portfolio in Ionis, 3.2% in Incyte (INCY), 3.4% in Biogen (BIIB), and 3.5% in bluebird bio (BLUE).

Check out all the data we have added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data as well as dividend info. Take a look!

Latest articles

Today, Slack (WORK) opened 4.5% higher after MKM Partners analyst Rohit Kulkarni gave Slack stock a "buy" rating with a target price of $40.

Pure Storage shares have risen more than 15% today. The company announced its second-quarter results after the markets closed on Wednesday.

Marijuana reform is central to Beto O’Rourke's 2020 presidential campaign—how could his agenda that affect the cannabis industry?

Nordstrom (JWN) stock was up 16% as of 11:50 AM today after it reported better-than-expected earnings for the second quarter of fiscal 2019.

Last month, four automakers, including Ford, made a voluntary deal with California to make cars cleaner and more fuel efficient. Trump isn't happy with the deal.

GameStop (GME) shares rose 8% in early market trading today. The company laid off about 120 employees as part of its restructuring process.